Product Program year 2023 Source: CMS Open Payments

Bludigo

Drug Marker dye

Open in the dashboard

General payments

$189,983

56 payments

Research payments

$48,910

15 payments

Through program year 2023, $189,983 in general payments and $48,910 in research payments were reported against Bludigo (Marker dye).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 General $136,136 48
2023 Research $42,635 11
2022 General $53,846 8
2022 Research $6,275 4

Breakdown

Who paid General payments · program years 2022–2023
  1. Provepharm Inc. $189,983 56 payments
Top recipients General payments · program year 2023
  1. Charles Pollack Emergency Medicine · Roswell, GA $60,009 44% · 3 payments
  2. Suzanne Gagnon Internal Medicine · North Wales, PA $59,800 44% · 6 payments
  3. Stephen Williams Urology · League City, TX $2,580 2% · 3 payments
  4. Lucas Wiegand Urology · Orlando, FL $2,000 1% · 1 payment
  5. Benjamin Brucker Urology · New York, NY $1,300 <1% · 1 payment

The top 5 of 32 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Emergency Medicine $60,009 44% · 1 practitioner
  2. Internal Medicine $59,800 44% · 1 practitioner
  3. Urology $13,779 10% · 19 practitioners
  4. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $1,300 <1% · 1 practitioner
  5. Urogynecology and Reconstructive Pelvic Surgery Urology $1,080 <1% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Pennsylvania $60,942 45% · 2 recipients
  2. Georgia $60,009 44% · 1 recipient
  3. Texas $4,893 4% · 11 recipients
  4. New York $4,884 4% · 4 recipients
  5. Florida $2,000 1% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

56 general · 15 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record